Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - 2,4-d as the iso-octyl ester - liquid concentrate - 2,4-d as the iso-octyl ester phenoxy acids-2,4-d-ester active 600.0 g/l - herbicide - barley | canola | cereal crop | cereal rye | direct drill | fallow, stubble spray prior to winter ce | grain legume | improved p - amaranth or amaranthus | angled onion | apple-of-sodom | bathurst burr | black knapweed | broadleaf weeds - see label | buffalo burr | californian burr | caltrop or yellow vine | camel or afghan melon | cape tulip | capeweed | cat's ear or flatweed | charlock | clover | colocynth | common vetch or tares | corn gromwell, ironweed or sheepweed | creeping/russian knapweed,hardhead | deadnettle | devil's-claw | dock | erodium, crowfoot or storksbill | fat hen | fumitory - red | fumitory - white | galvanised burr | golden thistle | goosefoot | grass weeds - see label | hedge or wild mustard | hoary cress or whiteweed | horehound | horehound - seedling | khaki weed | lincoln weed, sand rocket or mustard | london rocket | lupins | medic | melilotus or hexham scent | mexican poppy | mintweed | muskweed | mustard | new zealand spinach | nodding thistle | noogoora burr | nutgrass | paddy melon | paterson's curse | ragwort | rough poppy | safflower | saffron thistle | sheep, shore or winged slender thistle | shepherd's

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

echem (aust) pty limited - mcpa present as the iso octyl ester - emulsifiable concentrate - mcpa present as the iso octyl ester phenoxy acids-mcpa-ester active 500.0 g/l - herbicide - barley | cereal rye | grass pasture | oats | pasture grass seed crop | triticale | wheat - bathurst burr | capeweed | charlock | dandelion - taraxacum officinale | fat hen | fumitory | hedge or wild mustard | lincoln weed, sand rocket or mustard | london rocket | noogoora burr | paterson's curse | saffron thistle | scotch thistle | skeleton weed | slender, shore or sheep thistle | spear or black thistle | stinkwort | turnip weed | variegated thistle | volunteer canola or rapeseed | volunteer safflower | volunteer sunflower | wild radish or radish weed | wild sage | wild turnip | blessed thistle | brassica campestris | brassica kaber | brassica rapa ssp. sylvestris | brassica rapa var. sylvestris | brassica sinapistrum | bull thistle | cabbage thistle | carduus marianus | cockleburr | common dandelion | cotton thistle | crambling mustard | echium lycopsis | echium spp. | english dandelion | european dandelion | false star thistle | giant mustard | hedge mustard | heraldic thistle | holy thistle | jointed charlock | lady's thistle | milk thistle | pink weed | purple bugloss | purple viper's bugloss |

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

david gray & co. pty limited - bromoxynil present as the n-octanoyl ester; mcpa present as the iso octyl ester; liquid hydrocarbon - emulsifiable concentrate - bromoxynil present as the n-octanoyl ester nitrile active 67.0 g/l; mcpa present as the iso octyl ester phenoxy acids-mcpa-ester active 67.0 g/l; liquid hydrocarbon solvent other 640.0 g/l - herbicide - lawn - bindy-eye | broadleaf weeds | jo-jo | bindii | bindy-eye | bogan flea | broadleaf grass | calotis hispidula | dwarf jo-jo | hairy jo-jo | jo-jo | onehunga | onehunga weed | soft bindy-eye | soliva anthemifolia | soliva sessilis | soliva spp. | star burr

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

dr. reddy’s laboratories, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1.      progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2.      undiagnosed abnormal genital bleeding. 3.      known, suspected, or history of breast cancer. 4.      active deep vein thrombosis, pulmonary embolism or history of these conditions. 5.      active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6.      known liver dysfunction or disease. 7.      known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone, usp capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone, usp capsules should not be used in women with any of the following conditions:

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

akorn - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: - progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. - known liver dysfunction or disease. - known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

banner pharmacaps - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: - progesterone capsules should not be used in patients with known hypersensitivity to itsingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. - known liver dysfunction or disease. - known or suspected pregnancy.